Financial Services Committee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Hatch-Waxman Integrity Act of 2019 This bill establishes certain limits on the filing of patent validity challenges with the Patent Trial and Appeal Board, particularly with respect to inter partes review.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Administrative remediesDrug safety, medical device, and laboratory regulationFraud offenses and financial crimesIntellectual propertyLicensing and registrationsPrescription drugsSecurities
Hatch-Waxman Integrity Act of 2019
USA116th CongressHR-990| House
| Updated: 2/6/2019
Hatch-Waxman Integrity Act of 2019 This bill establishes certain limits on the filing of patent validity challenges with the Patent Trial and Appeal Board, particularly with respect to inter partes review.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Administrative remediesDrug safety, medical device, and laboratory regulationFraud offenses and financial crimesIntellectual propertyLicensing and registrationsPrescription drugsSecurities